Shandong Sanyuan Shares Owned By Insiders vs. Total Debt

301206 Stock   28.00  0.09  0.32%   
Considering Shandong Sanyuan's profitability and operating efficiency indicators, Shandong Sanyuan Biotechnology may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in January. Profitability indicators assess Shandong Sanyuan's ability to earn profits and add value for shareholders.
For Shandong Sanyuan profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Shandong Sanyuan to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Shandong Sanyuan Biotechnology utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Shandong Sanyuan's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Shandong Sanyuan Biotechnology over time as well as its relative position and ranking within its peers.
  
Check out Trending Equities.
Please note, there is a significant difference between Shandong Sanyuan's value and its price as these two are different measures arrived at by different means. Investors typically determine if Shandong Sanyuan is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Shandong Sanyuan's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Shandong Sanyuan Bio Total Debt vs. Shares Owned By Insiders Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Shandong Sanyuan's current stock value. Our valuation model uses many indicators to compare Shandong Sanyuan value to that of its competitors to determine the firm's financial worth.
Shandong Sanyuan Biotechnology is number one stock in shares owned by insiders category among its peers. It also is the top company in total debt category among its peers making up about  4,361,952  of Total Debt per Shares Owned By Insiders. Comparative valuation analysis is a catch-all model that can be used if you cannot value Shandong Sanyuan by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Shandong Sanyuan's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

Shandong Total Debt vs. Shares Owned By Insiders

Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.

Shandong Sanyuan

Insiders Shares

 = 

Executives Shares

+

Employees

 = 
62.45 %
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.

Shandong Sanyuan

Total Debt

 = 

Bonds

+

Notes

 = 
272.4 M
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.

Shandong Total Debt vs Competition

Shandong Sanyuan Biotechnology is the top company in total debt category among its peers. Total debt of Consumer Staples industry is presently estimated at about 4.24 Billion. Shandong Sanyuan holds roughly 272.4 Million in total debt claiming about 6% of stocks in Consumer Staples industry.
Total debt  Valuation  Capitalization  Revenue  Workforce

Shandong Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Shandong Sanyuan. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Shandong Sanyuan position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Shandong Sanyuan's important profitability drivers and their relationship over time.

Use Shandong Sanyuan in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Shandong Sanyuan position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Shandong Sanyuan will appreciate offsetting losses from the drop in the long position's value.

Shandong Sanyuan Pair Trading

Shandong Sanyuan Biotechnology Pair Trading Analysis

The ability to find closely correlated positions to Shandong Sanyuan could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Shandong Sanyuan when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Shandong Sanyuan - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Shandong Sanyuan Biotechnology to buy it.
The correlation of Shandong Sanyuan is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Shandong Sanyuan moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Shandong Sanyuan Bio moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Shandong Sanyuan can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Shandong Sanyuan position

In addition to having Shandong Sanyuan in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Communication Thematic Idea Now

Communication
Communication Theme
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Communication theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Communication Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in Shandong Stock

To fully project Shandong Sanyuan's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Shandong Sanyuan Bio at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Shandong Sanyuan's income statement, its balance sheet, and the statement of cash flows.
Potential Shandong Sanyuan investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Shandong Sanyuan investors may work on each financial statement separately, they are all related. The changes in Shandong Sanyuan's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Shandong Sanyuan's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.